DUSPATALIN

This brand name is authorized in Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Lithuania, Mexico, Poland, Romania, Singapore, Tunisia, Turkey

Active ingredients

The drug DUSPATALIN contains one active pharmaceutical ingredient (API):

1 Mebeverine
UNII 15VZ5AL4JN - MEBEVERINE HYDROCHLORIDE

Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility.

Read about Mebeverine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DUSPATALIN Modified release capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A03AA04 Mebeverine A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AA Synthetic anticholinergics, esters with tertiary amino group
Discover more medicines within A03AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 500214050031608, 500216020034303
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00009923, 00009946, 00055248, 00111573, 01184700, 01184717, 02742349, 02742355, 06467124, 06467130, 12490966, 16352899
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29.200-03-10, 5860-MEE-0121
Country: EE Ravimiamet Identifier(s): 1136696, 1885181
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 53900
Country: FR Base de données publique des médicaments Identifier(s): 61703401
Country: HK Department of Health Drug Office Identifier(s): 32074, 38954
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1015607, 1070284, 1079069, 1081606
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 259M2009, 314M2002
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100020985, 100078507, 100261074, 100266746, 100274036, 100292241, 100300294, 100301365, 100303619, 100306428, 100312156, 100325064, 100332710, 100343375, 100348616, 100350079, 100369512, 100385400, 100390104, 100392379, 100407661, 100421098, 100421721, 100424702, 100426322, 100429504, 100433658, 100457086, 100464331
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69081001, W69081002
Country: SG Health Sciences Authority Identifier(s): 07666P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 9003741
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699820030360, 8699820120030, 8699820700041

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.